Xanthotoxol exerts neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia

Cellular and Molecular Neurobiology

Volumn 33, Issue 5, 2013, Pages 715-722

  He, Wei ^a   Chen, Weiwei ^a   Zhou, Yumei ^a   Tian, Yuantong ^a   Liao, Fang ^a  

^a GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia reperfusion; Inflammatory response; Xanthotoxol

Indexed keywords

COUMARIN DERIVATIVE; CYCLOOXYGENASE 2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; NEUROPROTECTIVE AGENT; NITRIC OXIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XANTHOTOXOL; CYTOKINE; FUROCOUMARIN DERIVATIVE; PTGS2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG PENETRATION; ENZYME ACTIVITY; IMMUNOREGULATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; ANIMAL; BRAIN CORTEX; CELL NUCLEUS; CEREBRAL INFARCTION; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PERMEABILITY; SPRAGUE DAWLEY RAT;

ANIMALIA; CNIDIUM MONNIERI; RATTUS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CELL NUCLEUS; CEREBRAL CORTEX; CEREBRAL INFARCTION; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; FUROCOUMARINS; INFLAMMATION; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TRANSCRIPTION FACTOR RELA;

EID: 84878745470     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9939-2     Document Type: Article

References (29)

1. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT (2009) Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 276(1):13-26
2. Candelario-Jalil E, González-Falcón A, García- Cabrera M, León OS, Fiebich BL (2007) Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem 100(4):1108-1120
3. Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa AC, Dianzani C, Danni O, Thiemermann C, Fantozzi R (2006) Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 530(1-2):70-80
4. Danielisova V, Burda J, Nemethova M, Gottlieb M (2011) Aminoguanidine administration ameliorates hippocampal damage after middle cerebral artery occlusion in rat. Neurochem Res 36(3):476-486
5. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10(1):95-112
6. He W, Chen WW, Ye HY, Zhou YM, Huang XH (2009) Inhibitory effects of xanthotoxol on neutrophil infiltration and brain edema induced by focal cerebral ischemia-reperfusion injury in rats. Chin Pharmacol Bull 25(5):668-672
7. Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66(3):232-245
8. Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87(5):779-789
9. Khan M, Sekhon B, Jatana M, Giri S, Gilg AG, Sekhon C, Singh I, Singh AK (2004) Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 76(4):519-527
10. Kleinig TJ, Vink R (2009) Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Curr Opin Neurol 22(3):294-301
11. Lian QS, Zhang ZZ, Shangguan Z, Zhou L, Pi RB, Xiang RD, Han Y, Zhang XY (1996) Studies on the anti-arrhythmic effect of xanthotoxol in experimental animals. Chin Tradit Herb Drugs 27(6):347-349
12. Lian QS, Zhang ZZ, Hu X, Zhou L, Ye HY, He W, Zhu ZP (1998) Studies on the anti-inflammatory effect of xanthotoxol in experimental animals. Chin Tradit Herb Drugs 29(2):102-104
13. Liu J, Lian Q, Zhou L, Zhou Q, He W, Zhu Z, Lai F (2005) Calcium antagonistic effect of xanthotoxol on isolated guinea pig atria. Zhong Yao Cai 28(4):319-321
14. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1):84-91
15. Ng TB, Liu F, Wang ZT (2000) Antioxidative activity of natural products from plants. Life Sci 66(8):709-723
16. Nogawa S, Zhang F, Ross ME, Iadecola C (1997) Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17(8):2746-2755
17. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C (1998) Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA 95(18):10966-10971
18. Rodríguez-Yáñez M, Castillo J (2008) Role of inflammatory markers in brain ischemia. Curr Opin Neurol 21(3):353-357
19. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90(15):7240-7244
20. Sethi OP, Anand KK, Gulati OD (1992) Evaluation of xanthotoxol for central nervous system activity. J Ethnopharmacol 36(3):239-247
21. Shangguan Z, Lian QS, Zeng J, Zhou Q, Pi RB, Liu JX, Yang JG (1997) Studies on the analgesic effect of xanthotoxol in experimental animals. Tradit Chin Drug Res Clin Pharmacol 8(1):45-46
22. Tas SW, Vervoordeldonk MJ, Tak PP (2009) Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer. Curr Gene Ther 9(3):160-170
23. Toda N, Ayajiki K, Okamura T (2009) Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 61(1):62-97
24. Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97-120
25. Villa P, Triulzi S, Cavalieri B, Di Bitondo R, Bertini R, Barbera S, Bigini P, Mennini T, Gelosa P, Tremoli E, Sironi L, Ghezzi P (2007) The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats. Mol Med 13(3-4):125-133
26. Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184(1-2):53-68
27. Xiang RD, Fu XH (1984) Studies on the chemical constituents of common cnidium(cnidium monnieri)(I). Chin Tradit Herb Drugs 15(9):14-15
28. Zeng J, Lian Q, Zhou Q, Zhou L, Ye H, Huang X (2003) Effect of xanthotoxol on contraction of rabbit thoracic aortic strips. Zhong Yao Cai 26(11):809-811
29. Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M (2005) Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab 25(1):30-40